[Anesthetic management for mitral valve replacement in a patient with idiopathic hypereosinophilic syndrome].
We have experienced anesthetic management for mitral valve replacement in a 48-year-old female with idiopathic hypereosinophilic syndrome. Preoperative examination showed mild biventricular dysfunction. Anesthesia was induced and maintained with meticulous administration of fentanyl and midazolam in 66% oxygen. Administration of dopamine, dobutamine and prostaglandin E1 contributed to reducing afterload and maintaining cardiac output. The operative and postoperative courses were uneventful. Hypereosinophilic syndrome is one of the identified causes of restrictive cardiomyopathy. Anesthesia for patients with hypereosinophilic syndrome must be carried out carefully, because heart or respiratory failure is the most dangerous complication. In patients with hypereosinophilic syndrome requiring general anesthesia, perioperative steroid cover is advisable. This may reduce or prevent serious lung complications.
Nonaka
A
A
Department of Anesthesiology, Yamanashi Medical University, Yamanashi 409-3898.
Suzuki
S
S
Imamura
M
M
Kumazawa
T
T
D000768:Anesthesia, General; D002313:Cardiomyopathy, Restrictive / Q000209:etiology / Q000517:prevention & control; D005260:Female; D019918:Heart Valve Prosthesis Implantation; D006801:Humans; D017681:Hypereosinophilic Syndrome / Q000150:complications*; D007431:Intraoperative Complications; D008775:Methylprednisolone / Q000008:administration & dosage; D008875:Middle Aged; D008944:Mitral Valve Insufficiency / Q000150:complications / Q000601:surgery*; D019990:Perioperative Care; D011183:Postoperative Complications; D012131:Respiratory Insufficiency / Q000209:etiology / Q000517:prevention & control
D008775:Methylprednisolone